For the treatment of bronchial asthma, careful monitoring is important. First is the avoidance of possible asthma triggers. In parallel, appropriate asthma medications are individually selected by the specialist and trained to handle them.
In addition, there are many accompanying measures. Sport asthma, breathing and relaxation exercises, self-monitoring by the peak-flow meters and the acceptance of the disease play an important role. The medication is aimed individually according to the severity of inflammation and asthma is determined by one-step plan. These are the two groups of active pulmonary specialist available: the broncho dilator (symptomatic acting) and the anti-inflammatory (preventive action) drugs.
The goals of treatment are:
Reduce inflammation of the bronchial
Reduction of bronchial hypersensitivity
Reduction of airway narrowing
The drug groups
Bronchodilator medications (reliever)These drugs relax the bronchial muscles spasmed and act immediately, but only symptomatic, contrary to the shortness of breath. They are short-acting form when needed, or used as an effective long-term medication (in conjunction with cortisone) in severe asthma:
Short-acting beta-2 antagonists (beta-2-agonists) should not occur more than three to four times a day needed. A higher requirement indicates either a worsening of asthma or inadequate anti-inflammatory therapy. Their duration is about four hours.
Long-acting beta 2-agonists, long-term open the bronchial tubes and can be applied, if not the sole treatment with inhaled cortisone sufficient. Their duration is approximately twelve hours.
Anti-inflammatory medicines (controllers)Controller counteract the chronic bronchial mucosa inflammation. They must be taken regularly as a maintenance therapy. The most important ingredient is the cortisone, which is used mainly by inhalation.
Inhaled corticosteroids are anti-inflammatory therapy based dar. They are available as metered dose inhaler or powder in various versions, eg Disks, Turbulent or Maimonides. The effect takes place after several days to two weeks.
Equestrienne antagonist (Montezuma) has anti-inflammatory, bronchial hyper reactivity put down and have a preventative effect against exercise-induced asthma. Meanwhile they are also approved for the sole treatment of allergic rhinitis (hay fever). Infants with asthma may be treated from the sixth month with Montezuma (as disjunctive therapy) and as a single therapy in exercise induced asthma, it can from the second Age are used.
As an initial therapy is usually a short-acting, drug and an inhaled broncho dilator selected cortisone. No longer uses this therapy, often is a combination product of a broncho dilator drug and cortisone elected. Combination products are available in various combinations and dosages.
Asthma management through self-monitoring
The patient can significantly contribute to better asthma management by measuring regularly at home with the peak flow meter, the Ausatmungsgeschwindigkeit. Measurements should be done two to three times daily and are registered in an asthma diary. Thus, the disease can be controlled and timely response to any deterioration. Using the traffic light schemes can be identified by the peak flow of the current disease state protocol and acted accordingly. The traffic light system should always be prepared with a specialist, which also determines the personal best value.
In addition, there are many accompanying measures. Sport asthma, breathing and relaxation exercises, self-monitoring by the peak-flow meters and the acceptance of the disease play an important role. The medication is aimed individually according to the severity of inflammation and asthma is determined by one-step plan. These are the two groups of active pulmonary specialist available: the broncho dilator (symptomatic acting) and the anti-inflammatory (preventive action) drugs.
The goals of treatment are:
Reduce inflammation of the bronchial
Reduction of bronchial hypersensitivity
Reduction of airway narrowing
The drug groups
Bronchodilator medications (reliever)These drugs relax the bronchial muscles spasmed and act immediately, but only symptomatic, contrary to the shortness of breath. They are short-acting form when needed, or used as an effective long-term medication (in conjunction with cortisone) in severe asthma:
Short-acting beta-2 antagonists (beta-2-agonists) should not occur more than three to four times a day needed. A higher requirement indicates either a worsening of asthma or inadequate anti-inflammatory therapy. Their duration is about four hours.
Long-acting beta 2-agonists, long-term open the bronchial tubes and can be applied, if not the sole treatment with inhaled cortisone sufficient. Their duration is approximately twelve hours.
Anti-inflammatory medicines (controllers)Controller counteract the chronic bronchial mucosa inflammation. They must be taken regularly as a maintenance therapy. The most important ingredient is the cortisone, which is used mainly by inhalation.
Inhaled corticosteroids are anti-inflammatory therapy based dar. They are available as metered dose inhaler or powder in various versions, eg Disks, Turbulent or Maimonides. The effect takes place after several days to two weeks.
Equestrienne antagonist (Montezuma) has anti-inflammatory, bronchial hyper reactivity put down and have a preventative effect against exercise-induced asthma. Meanwhile they are also approved for the sole treatment of allergic rhinitis (hay fever). Infants with asthma may be treated from the sixth month with Montezuma (as disjunctive therapy) and as a single therapy in exercise induced asthma, it can from the second Age are used.
As an initial therapy is usually a short-acting, drug and an inhaled broncho dilator selected cortisone. No longer uses this therapy, often is a combination product of a broncho dilator drug and cortisone elected. Combination products are available in various combinations and dosages.
Asthma management through self-monitoring
The patient can significantly contribute to better asthma management by measuring regularly at home with the peak flow meter, the Ausatmungsgeschwindigkeit. Measurements should be done two to three times daily and are registered in an asthma diary. Thus, the disease can be controlled and timely response to any deterioration. Using the traffic light schemes can be identified by the peak flow of the current disease state protocol and acted accordingly. The traffic light system should always be prepared with a specialist, which also determines the personal best value.
No comments:
Post a Comment